Search a title or topic

Over 20 million podcasts, powered by 

Player FM logo
Artwork

Content provided by a16z, Andreessen Horowitz, and A16z Bio + Health. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by a16z, Andreessen Horowitz, and A16z Bio + Health or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://staging.podcastplayer.com/legal.
Player FM - Podcast App
Go offline with the Player FM app!

The History and Future of CAR T with Bruce Levine

31:26
 
Share
 

Manage episode 432821618 series 2790733
Content provided by a16z, Andreessen Horowitz, and A16z Bio + Health. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by a16z, Andreessen Horowitz, and A16z Bio + Health or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://staging.podcastplayer.com/legal.

Bruce Levine, PhD, the Barbara and Edward Netter Professor in Cancer Gene Therapy at the University of Pennsylvania, joins Jorge Conde, general partner, and Ginger Liau, partner at a16z Bio + Health.

Bruce talks about how his time working in a lab at the Children’s Hospital of Philadelphia inspired him to work on translational therapies. Together, they also discuss barriers to access for cancer therapeutics and how the fight against cancer is progressing.

Additional disclosures for Bruce include:

Scientific Advisory Boards: Avectas, Capstan (Chair), Immuneel, Immusoft, In8bio, Ori Biotech, Oxford Biomedica, ThermoFisher Pharma Services, UTC Therapeutics. Scientific Advisor: Kite. Past: Akron, Vycellix

Co-Founder and equity holder: Tmunity Therapeutics (acquired by Kite), Capstan Therapeutics

Board of Directors: Alliance for Cancer Gene Therapy

Conflict of interest is managed in accordance with University of Pennsylvania policy and oversight.

  continue reading

181 episodes

Artwork
iconShare
 
Manage episode 432821618 series 2790733
Content provided by a16z, Andreessen Horowitz, and A16z Bio + Health. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by a16z, Andreessen Horowitz, and A16z Bio + Health or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://staging.podcastplayer.com/legal.

Bruce Levine, PhD, the Barbara and Edward Netter Professor in Cancer Gene Therapy at the University of Pennsylvania, joins Jorge Conde, general partner, and Ginger Liau, partner at a16z Bio + Health.

Bruce talks about how his time working in a lab at the Children’s Hospital of Philadelphia inspired him to work on translational therapies. Together, they also discuss barriers to access for cancer therapeutics and how the fight against cancer is progressing.

Additional disclosures for Bruce include:

Scientific Advisory Boards: Avectas, Capstan (Chair), Immuneel, Immusoft, In8bio, Ori Biotech, Oxford Biomedica, ThermoFisher Pharma Services, UTC Therapeutics. Scientific Advisor: Kite. Past: Akron, Vycellix

Co-Founder and equity holder: Tmunity Therapeutics (acquired by Kite), Capstan Therapeutics

Board of Directors: Alliance for Cancer Gene Therapy

Conflict of interest is managed in accordance with University of Pennsylvania policy and oversight.

  continue reading

181 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Listen to this show while you explore
Play